The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Recombinant Human Serum Albumin Market Research Report 2024
Synopsis
Recombinant Human Serum Albumin (Rec. HSA) is animal origin free expressed in E.coli without animal or human derived raw materials. It is also free from other contaminating serum proteins.
Recombinant human serum albumin (rHSA) is genetically engineered and derived from a rice-based expression system. It is a highly purified and completely animal-, virus-, and bacteria-free product that was developed as an alternative to plasma-derived HSA, to which it is structurally equivalent.
The global Recombinant Human Serum Albumin market was valued at US$ 75 million in 2023 and is anticipated to reach US$ 121.1 million by 2030, witnessing a CAGR of 7.2% during the forecast period 2024-2030.
Global key players of recombinant human serum albumin (Recombinant Human Serum Albumin) include Albumedix, Merck and Ventria (InVitria). The top three manufacturers account for about 88% of the global share. North America is the largest producer of recombinant albumin in the world with about 46% share, followed by Europe and China with 42% and 7% share respectively. North America is the largest market with approximately 59% share, followed by Europe and China with approximately 29% and 6% market share, respectively. In terms of product type, ScrHSA is the largest segment, holding about 91% share. In terms of application, cell culture media is the largest downstream segment with about 73% share; followed by medical supplements.
This report aims to provide a comprehensive presentation of the global market for Recombinant Human Serum Albumin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Human Serum Albumin.
Report Scope
The Recombinant Human Serum Albumin market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Recombinant Human Serum Albumin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Recombinant Human Serum Albumin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Albumedix
Merck
Ventria (InVitria)
NCPC
Oryzogen
HiMedia
Segment by Type
OsrHSA
ScrHSA
Segment by Application
Cell Culture Media
Medical Supplements
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Recombinant Human Serum Albumin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Recombinant Human Serum Albumin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Recombinant Human Serum Albumin (Rec. HSA) is animal origin free expressed in E.coli without animal or human derived raw materials. It is also free from other contaminating serum proteins.
Recombinant human serum albumin (rHSA) is genetically engineered and derived from a rice-based expression system. It is a highly purified and completely animal-, virus-, and bacteria-free product that was developed as an alternative to plasma-derived HSA, to which it is structurally equivalent.
The global Recombinant Human Serum Albumin market was valued at US$ 75 million in 2023 and is anticipated to reach US$ 121.1 million by 2030, witnessing a CAGR of 7.2% during the forecast period 2024-2030.
Global key players of recombinant human serum albumin (Recombinant Human Serum Albumin) include Albumedix, Merck and Ventria (InVitria). The top three manufacturers account for about 88% of the global share. North America is the largest producer of recombinant albumin in the world with about 46% share, followed by Europe and China with 42% and 7% share respectively. North America is the largest market with approximately 59% share, followed by Europe and China with approximately 29% and 6% market share, respectively. In terms of product type, ScrHSA is the largest segment, holding about 91% share. In terms of application, cell culture media is the largest downstream segment with about 73% share; followed by medical supplements.
This report aims to provide a comprehensive presentation of the global market for Recombinant Human Serum Albumin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Human Serum Albumin.
Report Scope
The Recombinant Human Serum Albumin market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Recombinant Human Serum Albumin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Recombinant Human Serum Albumin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Albumedix
Merck
Ventria (InVitria)
NCPC
Oryzogen
HiMedia
Segment by Type
OsrHSA
ScrHSA
Segment by Application
Cell Culture Media
Medical Supplements
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Recombinant Human Serum Albumin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Recombinant Human Serum Albumin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Recombinant Human Serum Albumin Market Overview
1.1 Product Overview and Scope of Recombinant Human Serum Albumin
1.2 Recombinant Human Serum Albumin Segment by Type
1.2.1 Global Recombinant Human Serum Albumin Market Value Comparison by Type (2024-2030)
1.2.2 OsrHSA
1.2.3 ScrHSA
1.3 Recombinant Human Serum Albumin Segment by Application
1.3.1 Global Recombinant Human Serum Albumin Market Value by Application: (2024-2030)
1.3.2 Cell Culture Media
1.3.3 Medical Supplements
1.3.4 Other
1.4 Global Recombinant Human Serum Albumin Market Size Estimates and Forecasts
1.4.1 Global Recombinant Human Serum Albumin Revenue 2019-2030
1.4.2 Global Recombinant Human Serum Albumin Sales 2019-2030
1.4.3 Global Recombinant Human Serum Albumin Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Recombinant Human Serum Albumin Market Competition by Manufacturers
2.1 Global Recombinant Human Serum Albumin Sales Market Share by Manufacturers (2019-2024)
2.2 Global Recombinant Human Serum Albumin Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Recombinant Human Serum Albumin Average Price by Manufacturers (2019-2024)
2.4 Global Recombinant Human Serum Albumin Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Recombinant Human Serum Albumin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Recombinant Human Serum Albumin, Product Type & Application
2.7 Recombinant Human Serum Albumin Market Competitive Situation and Trends
2.7.1 Recombinant Human Serum Albumin Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Recombinant Human Serum Albumin Players Market Share by Revenue
2.7.3 Global Recombinant Human Serum Albumin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Recombinant Human Serum Albumin Retrospective Market Scenario by Region
3.1 Global Recombinant Human Serum Albumin Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Recombinant Human Serum Albumin Global Recombinant Human Serum Albumin Sales by Region: 2019-2030
3.2.1 Global Recombinant Human Serum Albumin Sales by Region: 2019-2024
3.2.2 Global Recombinant Human Serum Albumin Sales by Region: 2025-2030
3.3 Global Recombinant Human Serum Albumin Global Recombinant Human Serum Albumin Revenue by Region: 2019-2030
3.3.1 Global Recombinant Human Serum Albumin Revenue by Region: 2019-2024
3.3.2 Global Recombinant Human Serum Albumin Revenue by Region: 2025-2030
3.4 North America Recombinant Human Serum Albumin Market Facts & Figures by Country
3.4.1 North America Recombinant Human Serum Albumin Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Recombinant Human Serum Albumin Sales by Country (2019-2030)
3.4.3 North America Recombinant Human Serum Albumin Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Recombinant Human Serum Albumin Market Facts & Figures by Country
3.5.1 Europe Recombinant Human Serum Albumin Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Recombinant Human Serum Albumin Sales by Country (2019-2030)
3.5.3 Europe Recombinant Human Serum Albumin Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Recombinant Human Serum Albumin Market Facts & Figures by Country
3.6.1 Asia Pacific Recombinant Human Serum Albumin Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Recombinant Human Serum Albumin Sales by Country (2019-2030)
3.6.3 Asia Pacific Recombinant Human Serum Albumin Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Recombinant Human Serum Albumin Market Facts & Figures by Country
3.7.1 Latin America Recombinant Human Serum Albumin Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Recombinant Human Serum Albumin Sales by Country (2019-2030)
3.7.3 Latin America Recombinant Human Serum Albumin Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Recombinant Human Serum Albumin Market Facts & Figures by Country
3.8.1 Middle East and Africa Recombinant Human Serum Albumin Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Recombinant Human Serum Albumin Sales by Country (2019-2030)
3.8.3 Middle East and Africa Recombinant Human Serum Albumin Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Recombinant Human Serum Albumin Sales by Type (2019-2030)
4.1.1 Global Recombinant Human Serum Albumin Sales by Type (2019-2024)
4.1.2 Global Recombinant Human Serum Albumin Sales by Type (2025-2030)
4.1.3 Global Recombinant Human Serum Albumin Sales Market Share by Type (2019-2030)
4.2 Global Recombinant Human Serum Albumin Revenue by Type (2019-2030)
4.2.1 Global Recombinant Human Serum Albumin Revenue by Type (2019-2024)
4.2.2 Global Recombinant Human Serum Albumin Revenue by Type (2025-2030)
4.2.3 Global Recombinant Human Serum Albumin Revenue Market Share by Type (2019-2030)
4.3 Global Recombinant Human Serum Albumin Price by Type (2019-2030)
5 Segment by Application
5.1 Global Recombinant Human Serum Albumin Sales by Application (2019-2030)
5.1.1 Global Recombinant Human Serum Albumin Sales by Application (2019-2024)
5.1.2 Global Recombinant Human Serum Albumin Sales by Application (2025-2030)
5.1.3 Global Recombinant Human Serum Albumin Sales Market Share by Application (2019-2030)
5.2 Global Recombinant Human Serum Albumin Revenue by Application (2019-2030)
5.2.1 Global Recombinant Human Serum Albumin Revenue by Application (2019-2024)
5.2.2 Global Recombinant Human Serum Albumin Revenue by Application (2025-2030)
5.2.3 Global Recombinant Human Serum Albumin Revenue Market Share by Application (2019-2030)
5.3 Global Recombinant Human Serum Albumin Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Albumedix
6.1.1 Albumedix Corporation Information
6.1.2 Albumedix Description and Business Overview
6.1.3 Albumedix Recombinant Human Serum Albumin Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Albumedix Recombinant Human Serum Albumin Product Portfolio
6.1.5 Albumedix Recent Developments/Updates
6.2 Merck
6.2.1 Merck Corporation Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Recombinant Human Serum Albumin Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Merck Recombinant Human Serum Albumin Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 Ventria (InVitria)
6.3.1 Ventria (InVitria) Corporation Information
6.3.2 Ventria (InVitria) Description and Business Overview
6.3.3 Ventria (InVitria) Recombinant Human Serum Albumin Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Ventria (InVitria) Recombinant Human Serum Albumin Product Portfolio
6.3.5 Ventria (InVitria) Recent Developments/Updates
6.4 NCPC
6.4.1 NCPC Corporation Information
6.4.2 NCPC Description and Business Overview
6.4.3 NCPC Recombinant Human Serum Albumin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 NCPC Recombinant Human Serum Albumin Product Portfolio
6.4.5 NCPC Recent Developments/Updates
6.5 Oryzogen
6.5.1 Oryzogen Corporation Information
6.5.2 Oryzogen Description and Business Overview
6.5.3 Oryzogen Recombinant Human Serum Albumin Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Oryzogen Recombinant Human Serum Albumin Product Portfolio
6.5.5 Oryzogen Recent Developments/Updates
6.6 HiMedia
6.6.1 HiMedia Corporation Information
6.6.2 HiMedia Description and Business Overview
6.6.3 HiMedia Recombinant Human Serum Albumin Sales, Revenue and Gross Margin (2019-2024)
6.6.4 HiMedia Recombinant Human Serum Albumin Product Portfolio
6.6.5 HiMedia Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Recombinant Human Serum Albumin Industry Chain Analysis
7.2 Recombinant Human Serum Albumin Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Recombinant Human Serum Albumin Production Mode & Process
7.4 Recombinant Human Serum Albumin Sales and Marketing
7.4.1 Recombinant Human Serum Albumin Sales Channels
7.4.2 Recombinant Human Serum Albumin Distributors
7.5 Recombinant Human Serum Albumin Customers
8 Recombinant Human Serum Albumin Market Dynamics
8.1 Recombinant Human Serum Albumin Industry Trends
8.2 Recombinant Human Serum Albumin Market Drivers
8.3 Recombinant Human Serum Albumin Market Challenges
8.4 Recombinant Human Serum Albumin Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
